Company events: according to the announcement of Guandian Defense Technology Co., Ltd. on the application for board transfer and its progress issued by the company on March 31, 2022, the company received the decision issued by Shanghai Stock Exchange on the same day and agreed to transfer the company to the science and Innovation Board of Shanghai stock exchange for listing.
The audit time of "the first share of the board transfer" is only 36 days, which is in line with the positioning of the science and innovation board + outstanding scientific and technological innovation ability: the company spent 99 days from submitting the application for the board transfer to the successful meeting; From the formal acceptance to the successful meeting, it took 78 days, and the audit took only 36 days. On July 27, 2020, the company became one of the first 32 enterprises in the selection layer; On November 15, 2021, the Beijing Stock Exchange opened for operation, and the company became the first batch of listed enterprises of the Beijing stock exchange; On October 20, 2021, the company submitted the application materials for listing on the science and innovation board to the Shanghai Stock Exchange, becoming the first enterprise to apply for listing on the science and Innovation Board of Shanghai Stock Exchange; On November 10, 2021, the company's application for board transfer was accepted; On December 3, 2021, the company received the first round of inquiry letter; By March 31, 2022, the company successfully obtained the decision of Shanghai Stock Exchange to approve the board transfer, becoming the first enterprise to hold the board transfer meeting, and the "first share of the board transfer" was officially born. In terms of scientific innovation strength, the company has independent core technology and outstanding scientific and technological innovation ability. From 2018 to June 2021, the R & D investment of the company was 9.1978 million yuan, 175801 million yuan, 201059 million yuan and 8.1576 million yuan respectively, accounting for 8.80%, 12.05%, 11.18% and 6.41% of the operating revenue respectively. As of the signing date of this listing report, the company has 74 patents, including 14 invention patents and 60 utility model patents. In the first half of 2021, the company signed the cooperation agreement on joint research center with Beijing University of Aeronautics and Astronautics; It was recognized as "the first batch of specialized special new 'little giant' enterprises in Beijing in 2021" by Beijing Municipal Bureau of economy and information technology, and the third batch of specialized special new 'little giant' enterprises by the Ministry of industry and information technology.
Based on flight service and data processing + UAV system and intelligent defense equipment, the net profit attributable to the parent company is expected to increase by 34.79% in 2021: Guandian defense was established in 2004 with complete military qualification. It is China's leading UAV drug control service provider and the first enterprise in China to engage in UAV drug control product R & D and service industrialization. The company's main business is UAV flight service and data processing, and the R & D, production and sales of UAV system and intelligent defense equipment. In terms of UAV flight service and data processing, the company has a wide range of business and has obvious competitive advantages in the field of drug control. Relevant scientific research projects have won the second prize of science and Technology issued by the Ministry of public security. The company has accumulated about 4 million square kilometers of image data, and the annual increment is no less than 300000 square kilometers. In terms of UAV system and intelligent defense equipment, the company has mastered core technologies in UAV overall design, flight control and aerodynamic optimization, creating a precedent for free take-off and landing flight of small UAVs in high altitude areas in China. In 2021, the company expects a revenue of 230 million yuan, with a year-on-year increase of 27.87%, and a net profit attributable to the parent company of 720594 million yuan, with a year-on-year increase of 34.79%. The increase is mainly due to the rapid growth of UAV flight service and data processing, UAV system and intelligent defense equipment sales business with the continuous improvement of the company's technical strength and the continuous expansion of application fields, the gradual achievement transformation of military projects and the rapid growth of UAV flight service and data processing.
Investment suggestion: Guandian defense actively integrates into the national strategic pattern of military civilian integration. Based on the four certificates of military industry and relying on technology and project reserves, Guandian defense gradually establishes and improves a military industrial system that conforms to the military civilian integration policy, adapts to the characteristics of aviation industry and has the characteristics of Guandian defense. The company's core anti drug services have strong profitability, large room for expansion and strong scientific and technological innovation. The market value before the suspension is 5.2 billion yuan. It is recommended to continue to pay attention.
Risk tips: supplier concentration risk, product renewal risk and brain drain risk
